
VU 0357121
CAS No. 433967-28-3
VU 0357121( VU-0357121, VU0357121, VU 0357121 )
Catalog No. M18548 CAS No. 433967-28-3
VU0357121, a positive allosteric modulator of mGlu5 (EC50: 33 nM), is inactive or very weakly antagonizing at other mGlu receptor subtypes.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 49 | In Stock |
![]() ![]() |
10MG | 78 | In Stock |
![]() ![]() |
25MG | 167 | In Stock |
![]() ![]() |
50MG | 332 | In Stock |
![]() ![]() |
100MG | 500 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameVU 0357121
-
NoteResearch use only, not for human use.
-
Brief DescriptionVU0357121, a positive allosteric modulator of mGlu5 (EC50: 33 nM), is inactive or very weakly antagonizing at other mGlu receptor subtypes.
-
DescriptionVU0357121 is a positive allosteric modulator of mGlu5 receptors (EC50 = 33 nM). Mutagenesis studies indicate that VU0357121 and related analogues bind to a yet uncharacterized allosteric site on mGlu(5), distinct from CPPHA, yet share a functional interaction with the MPEP site.
-
In VitroVU 0357121 has the ability to enhance glutamate sensitivity of mGlu5 is likely due to the interaction at a site on the receptor distinct from the MPEP binding site. VU 0357121 does not bind at the MPEP allosteric site of mGlu5, thus does not possess mGlu5 NAM activity. The A809V/rmGlu5 mutation inhibited the ability of VU 0357121 to shift the glutamate concentration response curve, whereas the response to VU 0357121 is not altered by the F585I/rmGlu5 mutation. VU 0357121 shows weaker cooperativity in the Ca2+ mobilization assay in the low-expressing HEK293A-mGlu5 cell line.
-
In Vivo——
-
SynonymsVU-0357121, VU0357121, VU 0357121
-
PathwayOthers
-
TargetOther Targets
-
RecptormGluR5
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number433967-28-3
-
Formula Weight305.32
-
Molecular FormulaC17H17F2NO2
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 50 mg/mL; 163.76 mM
-
SMILESCCCCOc1ccc(cc1)C(=O)Nc1c(cc(cc1)F)F
-
Chemical Name4-Butoxy-N-(2,4-difluorophenyl)benzamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Hammond AS, et al. ACS Chem Neurosci, 2010, 1(10), 702-716.
molnova catalog



related products
-
MI-3454
MI-3454 is an orally active, selective and potent inhibitor of Menin-MLL1 interaction that inhibits the proliferation and induces differentiation of acute leukemia cells with MLL1 translocation or NPM1 mutation.
-
PAT-1251
PAT-1251 (PAT 1251, PAT1251) is a?potent, selective and orally bioavailable lysyl oxidase-like 2 (LOXL2) inhibitor with IC50 of 0.71 uM in human whole blood assays.
-
Cemiplimab
Cemiplimab (Anti-Human PD-1) is a human monoclonal antibody that inhibits the PD-1/PD-L1 pathway, serving as a checkpoint inhibitor.